Reply to: Optimal dosing and duration of linezolid in multidrug-resistant tuberculosis: methodological and clinical appraisal. Kwak N, Kim JY, Han A, Hahn S, et al. Eur Respir J 2026;67:2502064.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kwak N, Kim JY, Han A, Hahn S, et al. Reply to: Optimal dosing and duration of linezolid in multidrug-resistant tuberculosis: methodological and clinical appraisal. Eur Respir J 2026;67:2502064.
PMID: 41571332